BlossomHill Therapeutics, Inc (BLSM) insider trading
Every open-market stock purchase and sale by BlossomHill Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Orbimed Advisors LLC (Director) and 5 others bought $25.2M in the last 90 days, growing their stake 30%.
Last 12 months: insiders bought $25.2M (6 buys) and sold $0 (0 sales). Last close $15.81 on Oct 22, 2026.
Recent BLSM insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 10, 2026 | Carl L Gordon (Director) | Bought | $10M |
| Aug 10, 2026 | Orbimed Advisors LLC (Director) | Bought | $10M |
| Aug 10, 2026 | Bihua Chen (Insider) | Bought | $5M |
| Aug 10, 2026 | John P. Schmid (Insider) | Bought | $96K |
| Aug 10, 2026 | Vincent Paul Liptak (General Counsel) | Bought | $35.2K |
| Aug 10, 2026 | Jason A Keyes (CFO) | Bought | $11.2K |
| Aug 10, 2026 | Yishan Li (Chair) | Bought (not open market) | — |
| Aug 10, 2026 | Yishan Li (Chair) | Bought (not open market) | — |
| Aug 10, 2026 | Bihua Chen (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | Bihua Chen (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | Bihua Chen (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | Bihua Chen (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | Orbimed Advisors LLC (Director) | Bought (not open market) | — |
| Aug 10, 2026 | Orbimed Advisors LLC (Director) | Bought (not open market) | — |
| Aug 10, 2026 | Orbimed Advisors LLC (Director) | Bought (not open market) | — |
| Aug 10, 2026 | Orbimed Advisors LLC (Director) | Bought (not open market) | — |
| Aug 10, 2026 | Carl L Gordon (Director) | Bought (not open market) | — |
| Aug 10, 2026 | Carl L Gordon (Director) | Bought (not open market) | — |
| Aug 10, 2026 | Carl L Gordon (Director) | Bought (not open market) | — |
| Aug 10, 2026 | Carl L Gordon (Director) | Bought (not open market) | — |
| Aug 10, 2026 | Sundeep Agrawal (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | Jingrong Jean Cui (CEO) | Bought (not open market) | — |
| Aug 10, 2026 | Jingrong Jean Cui (CEO) | Bought (not open market) | — |
| Aug 10, 2026 | Vincent Paul Liptak (General Counsel) | Bought (not open market) | — |
| Aug 10, 2026 | Jingrong Jean Cui (CEO) | Bought (not open market) | — |
Who's trading BLSM
- John P. Schmid, Insider: bought $96K (1 buy), last Aug 10, 2026
- Bihua Chen, Insider: bought $5M (1 buy), last Aug 10, 2026
- Jingrong Jean Cui, CEO: other filings, last Aug 10, 2026
- Carl L Gordon, Director: bought $10M (1 buy), last Aug 10, 2026
- Jason A Keyes, CFO: bought $11.2K (1 buy), last Aug 10, 2026
- Yishan Li, Chair: other filings, last Aug 10, 2026
- Vincent Paul Liptak, General Counsel: bought $74.7K (2 buys), last Aug 10, 2026
- Orbimed Advisors LLC, Director: bought $10M (1 buy), last Aug 10, 2026
- Sundeep Agrawal, Insider: other filings, last Aug 10, 2026
- Geoffrey Raymond Oxnard, C-suite exec: other filings, last Aug 6, 2026
Get free alerts when an insider at BlossomHill Therapeutics, Inc files a new trade →